{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:48:32Z","timestamp":1760204912204,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejca.2017.07.014","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T10:40:08Z","timestamp":1502188808000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Survival for patients with rare haematologic malignancies: Changes in the early 21st century"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-6206","authenticated-orcid":false,"given":"Dianne","family":"Pulte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janick","family":"Weberpals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Luttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Nennecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meike","family":"Ressing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Geiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Luttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Stabenow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Nennecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Kieschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice","family":"Sirri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiltraud","family":"Kaj\u00fcter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkmar","family":"Mattauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Eisemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kraywinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janick","family":"Weberpals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejca.2017.07.014_bib1","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1002\/cncr.24548","article-title":"Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981\u20132005","volume":"115","author":"Pulte","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.014_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3324\/haematol.2012.063602","article-title":"Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups","volume":"98","author":"Pulte","year":"2013","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.ejca.2017.07.014_bib3","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/cncr.30003","article-title":"Changes in the survival of older patients with hematologic malignancies in the early 21st century","volume":"122","author":"Pulte","year":"2016","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.014_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(14)70282-7","article-title":"Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study","volume":"15","author":"Sant","year":"2014","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2017.07.014_bib5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3109\/02841861003631495","article-title":"Trends in the survival of patients diagnosed with malignant neoplasms of the lymphoid, hematopoietic, and related tissue in the Nordic countries 1964\u20132003 followed up to the end of 2006","volume":"49","author":"Storm","year":"2010","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2017.07.014_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ejh.12468","article-title":"Survival for patients with chronic leukemia in the US and Britain: age-related disparities and changes in the early 21st century","volume":"94","author":"Pulte","year":"2015","journal-title":"Eur J Haematol"},{"issue":"14","key":"10.1016\/j.ejca.2017.07.014_bib7","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/cncr.28106","article-title":"Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis","volume":"119","author":"Brunner","year":"2013","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.ejca.2017.07.014_bib8","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population","volume":"34","author":"Bower","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.07.014_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-016-0257-2","article-title":"Trends in survival of chronic lymphocytic leukemia in Germany and in the USA in the first decade of the twenty-first century","volume":"9","author":"Pulte","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.07.014_bib10","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1634\/theoncologist.2011-0229","article-title":"Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data","volume":"16","author":"Pulte","year":"2011","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.014_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/COC.0b013e3182a4676b","article-title":"Emerging therapies in multiple myeloma","volume":"38","author":"El-Amm","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2017.07.014_bib12","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2352-3026(15)00155-6","article-title":"Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5)","volume":"2","author":"Mounier","year":"2015","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.ejca.2017.07.014_bib13","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/ijc.29316","article-title":"Recent cancer survival in Germany: an analysis of common and less common cancers","volume":"136","author":"Jansen","year":"2015","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.014_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/annonc\/mdr131","article-title":"Survival from common and rare cancers in Germany in the early 21st century","volume":"23","author":"Hiripi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.07.014_bib15","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.3324\/haematol.2016.157768","article-title":"Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century","volume":"102","author":"Weberpals","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.ejca.2017.07.014_bib16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jgh.12989","article-title":"Survival of patients with gastric lymphoma in Germany and in the United States","volume":"30","author":"Castro","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2017.07.014_bib17","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2013), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2016, based on the November 2015 submission."},{"key":"10.1016\/j.ejca.2017.07.014_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1014380323037","article-title":"Projecting SEER cancer survival rates to the US: an ecological regression approach","volume":"13","author":"Mariotto","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejca.2017.07.014_bib19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejca.2003.10.013","article-title":"Period analysis for up-to-date cancer survival data: theory, empirical evaluation, computational realization and applications","volume":"40","author":"Brenner","year":"2004","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2017.07.014_bib20","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#","article-title":"An alternative approach to monitoring cancer patient survival","volume":"78","author":"Brenner","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2017.07.014_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/intjepid\/31.2.456","article-title":"Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland","volume":"31","author":"Brenner","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.014_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.2002.20.3.826","article-title":"Up-to-date long-term survival curves of patients with cancer by period analysis","volume":"20","author":"Brenner","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.07.014_bib23","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.ejca.2004.07.002","article-title":"Standard cancer patient population for age standardizing survival ratios","volume":"40","author":"Corazziari","year":"2004","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2017.07.014_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/aje\/kwj243","article-title":"Up-to-date and precise estimates of cancer patient survival: model-based period analysis","volume":"164","author":"Brenner","year":"2006","journal-title":"Am J Epidemiol"},{"year":"1959","series-title":"Instructions to IBM 650 programmers in processing survival computations","author":"Ederer","key":"10.1016\/j.ejca.2017.07.014_bib25"},{"key":"10.1016\/j.ejca.2017.07.014_bib26","unstructured":"Federal Statistical Office Germany: GENESIS-Online database. https:\/\/www-genesis.destatis.de\/genesis\/online. [Accessed December 2013]."},{"key":"10.1016\/j.ejca.2017.07.014_bib27","first-page":"1","article-title":"United States life tables, 2000","author":"Arias","year":"2002","journal-title":"Natl Vit Stat Rep"},{"key":"10.1016\/j.ejca.2017.07.014_bib28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0959-8049(02)00003-5","article-title":"A computer program for period analysis of cancer patients survival","volume":"38","author":"Brenner","year":"2002","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2017.07.014_bib29","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3324\/haematol.13045","article-title":"Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level","volume":"93","author":"Brenner","year":"2008","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.ejca.2017.07.014_bib30","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","article-title":"Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial","volume":"124","author":"Hoelzer","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejca.2017.07.014_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1470-2045(15)00447-7","article-title":"Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicenter, randomized, open-label, non-inferiority phase 3 trial","volume":"17","author":"Rummel","year":"2016","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejca.2017.07.014_bib32","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1505237","article-title":"Lenalidomide plus rituximab as initial treatment for mantle-cell lymphoma","volume":"373","author":"Ruan","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ejca.2017.07.014_bib33","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mater T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejca.2017.07.014_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1345\/aph.1Q680","article-title":"Brentuximab vedotin: a new age in the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma","volume":"46","author":"Minich","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejca.2017.07.014_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.leukres.2017.02.001","article-title":"Outcome disparities by insurance type for patients with acute myeloblastic leukemia","volume":"56","author":"Pulte","year":"2017","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.ejca.2017.07.014_bib36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1634\/theoncologist.2014-0386","article-title":"Survival disparities by insurance type for patients aged 15\u201364 years with non-Hodgkin lymphoma","volume":"20","author":"Pulte","year":"2014","journal-title":"Oncologist"},{"issue":"20","key":"10.1016\/j.ejca.2017.07.014_bib37","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasm and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.ejca.2017.07.014_bib38","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917311243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917311243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T13:53:27Z","timestamp":1535550807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917311243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":38,"alternative-id":["S0959804917311243"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.014","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival for patients with rare haematologic malignancies: Changes in the early 21st century","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}